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Summary The glycolipid content of human non-seminomatous germ cell tumour cell lines correlates with their
differentiation lineage. To analyse whether this reflects the situation in primary tumours, we studied five
embryonal carcinomas, five yolk sac tumours and nine (mixed) non-seminomas, using thin-layer
chromatography and carbohydrate immunostaining. We also analysed the glycolipid content of 19 seminomas
to reveal their relationship with non-seminomas. Lactosylceramide (CDH) was detected in all embryonal
carcinomas, but in fewer than half of the seminomas. Seminomas and embryonal carcinomas contained globo-
series glycolipids, including globotriosylceramide (Gb3), globoside (Gb4), galactosyl globoside (Gb5) and sialyl
galactosyl globoside (GL7). The lacto-series glycolipid Lex was found in all embryonal carcinomas, but only in
one seminoma. Gangliosides GD3 and GT3 were detected in many seminomas, but rarely in embryonal
carcinomas. Yolk sac tumours displayed a heterogeneous glycolipid profile. Compared with seminomas and
pure embryonal carcinomas, differentiated non-seminomas had reduced levels of globo-series glycolipids,
especially Gb3 and Gb5, whereas CDH, Lex, GD3 and GT3 were found in the majority of cases. Thus, the
glycolipid content of non-seminoma cell lines reflects the situation in primary tumours. Globo-series glycolipids
are similarly expressed in seminomas and embryonal carcinomas. The expression of Gb3 and Gb5 is reduced in
non-seminomas upon differentiation. Lex expression in non-seminomas, including embryonal carcinomas,
allows discrimination from seminomas. Expression of gangliosides in seminomas might indicate their
maturation from ganglioside-negative precursor cells. Reprogramming of these precursors would result in the
formation of Lex-expressing embryonal carcinomas.
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In humans, two entities of testicular germ cell tumours
(TGCTs) of adolescents and adults can be distinguished:
seminomas (SEs), which are composed of tumour cells that
are considered to be the malignant counterpart of human
primordial germ cells, and non-seminomatous TGCTs (NSs),
comprising embryonal carcinoma (EC, the undifferentiated
stem cells of human NSs), immature and mature teratoma
(IT and MT), yolk sac tumour (YS) and choriocarcinoma
(CC) (Mostofi et al., 1987). The relationship between SEs and
NSs is a matter of debate. Several investigators suggest that
SE and NS are biologically independent (Pierce and Abell,
1970; Mostofi, 1984; Sesterhenn, 1985), whereas others
assume that NS develops through a, not necessarily clinically
manifest, SE stage (Friedman, 1951; Oliver, 1987; Oosterhuis
et al., 1989; Oosterhuis and Looijenga, 1993). According to
this so-called linear progression model, SE cells become
'reprogrammed' to EC cells. This hypothesis is supported by
morphological, ultrastructural, immunohistochemical (inter-
phase), chromosomal and clinical analyses (Oosterhuis et al.,
1989; De Jong et al., 1990; Oliver, 1990; Czernobilsky, 1991;
Fossa et al., 1991; Czaja and Ulbright, 1992; El-Naggar et al.,
1992; Looijenga et al., 1993).
The study ofhuman NSs is facilitated by the existence ofcell
lines representing most non-seminomatous cell types (Pattillo et
al., 1971; Fogh and Trempe, 1975; Andrews et al., 1980;
Oosterhuis et al., 1985; Casper et al., 1987; Pera et al., 1987;
Damjanov et al., 1993; von Keitz et al., 1995). Experiments can
be performed using cell lines ofpluripotent EC cells, which can
be induced to differentiate by exposure to certain agents (e.g.
retinoic acid and hexamethylene bisacetamide), for example
allowing analysis ofchanges in gene expression responsible for,
or coinciding with, the process ofdifferentiation. Some ofthese
studies have focused on the expression of cell-surface
glycolipids, i.e. molecules composed of a carbohydrate and a
lipid moiety. Various groups ofglycolipids can be distinguished
according to their basic molecular structure (IUPAC-IUB,
1978). The three main groups are the so called globo-, lacto-,
and ganglio-series glycolipids (Svennerholm, 1964). Among
others, glycolipids are involved in early embryonic develop-
ment and in mediation/modification of growth factor action
(Bird and Kimber, 1984; Bremer et al., 1984; Fenderson et al.,
1984; Cuello et al., 1989; Eggens et al., 1989). Therefore,
glycolipids might be important in the development ofTGCTs.
The patterns ofglycolipid expression in non-seminomatous cell
lines correlate with their differentiation lineage. Andrews et al.
(1990) and Wenk et al. (1994) have shown that EC cell lines are
characterised by the expression of globo-series glycolipids,
including globotriosylceramide (Gb3), globoside (Gb4),
galactosylgloboside (Gb5) and sialyl galactosylgloboside
(GL7). Upon induced or spontaneous differentiation of these
cells into the various non-seminomatous cell types the synthesis
of globo-series glycolipids is down-regulated, whereas the
synthesis of lacto-, and ganglio-series glycolipids (including
Lex, and GD3/GT3 respectively) increases. Cell lines derived
from YSs can contain Gb3, Gb4 and gangliosides, whereas CC
cell lines mainly express Gb3 and the stage-specific embryonic
antigen 1 (SSEA-1)-carrying lacto-series glycolipid Lex (Wenk
et al., 1994). Thus, specific combinations of glycolipids are
correlated with specific cell types and the way in which the
various cell types are related can be studied using glycolipid
analysis. No extensive data on the glycolipid pattern ofprimary
SEs and NSs have been reported (Ohyama et al., 1990, 1992),
we therefore studied the glycolipids of carcinoma in situ (CIS,
the precursor of all TGCTs; Skakkebaek et al., 1987) and
primary TGCTs to reveal the relationship between SEs and
NSs, especially ECs.
Materials and methods
Tumour handling
Fourty-nine orchidectomy specimens, suspected of a germ cell
tumour were collected in the operation theatre or pathology
department of collaborating hospitals. Representative parts
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of tumour and adjacent normal parenchyma were snap frozen
using liquid nitrogen. The remaining parts were put in culture
medium [Dulbecco's modified Eagle medium (DMEM)F12,
with 103 kU 11 penicillin, 103 mg I1 streptomycin,
43 mg 1` gentamycin, 365 mg `1 glutamin, Gibco, Paisley,
UK] and taken to the laboratory for further processing.
Tumour diagnosis was based on microscopic interpretation of
a haematoxylin and eosin-stained 5 ,um frozen tissue section.
Fresh representative samples of all tissue components were
fixed in 4% (v/v) formalin for paraffin embedding, or snap
frozen in liquid nitrogen. Remaining tumour parts were
dissociated in culture medium at room temperature, using
two crossed scalpel blades. Tissue fragments were allowed to
settle in a 50 ml tube in 30 ml of culture medium. The
supernatant, containing mostly single cells (as analysed by
phase-contrast microscopy using a Zeiss Axiovert micro-
scope), was washed twice with culture medium. To the cell
suspension 10% (final volume) dimethyl sulphoxide was
added slowly. The suspension was aliquoted, frozen in a
Kryo 10 Series 2 automated freezer (Planer Biomed,
Sunbury-on-Thames, UK) and stored in liquid nitrogen.
Tumour characterisation
Typing according to the WHO classification (Mostofi, 1980,
1984) was based on histology and immunohistochemical
analysis of expression of germ cell-specific alkaline phospha-
tase (detected with antibodies to placenta-like alkaline
phosphatase), a-fetoprotein, human chorionic gonadotropin
(Dako, Glostrup, Denmark) and cytokeratins 8 and 18
(Beckton Dickinson, San Jose, CA, USA) using representa-
tive paraffin and frozen tissue sections (Oosterhuis et al.,
1989).
Classification revealed 19 SEs and 19 NSs, the latter
comprising five pure ECs, one MT, five YSs, one testicular
Wilms' tumour of germ cell origin (Gillis et al., 1994) and
seven mixed tumours. The mixed NSs comprised two
tumours with EC, IT, MT and YS, one with IT, MT, YS
and CC, one with MT and YS, and one with IT, MT and
YS. Separate tumour nodules were used from two other
mixed tumours; one with EC, IT, MT and YS besides EC
with MT, the other with two SE nodules besides an EC
component. The separate samples from these two tumours
are referred to as T,, T2 and T3 (for the latter), and are
regarded as individual tumours. Besides the above-mentioned
tumours, two normal parenchyma with active spermatogen-
esis and two abundantly CIS-containing parenchyma were
analysed, as were a spermatocytic seminoma (SS), one YS
derived from a xenografted mixed NS (TL37), one dermoid
cyst and two testicular B-cell lymphomas.
Lymphocyte depletion
Cryopreserved single cell suspensions from five SEs, contain-
ing SE cells and lymphocytes, were rapidly thawed at 37°C,
washed in 10 ml of culture medium and counted. The
suspensions were treated with a 2.5-fold excess (relative to
the total cell number) of magnetic beads coated with anti-
CD2 monoclonal antibody (Dynal, Skoyen, Norway) to
deplete lymphocytes. After 15-20 min incubation at room
temperature with gentle shaking, 4 ml ofculture medium was
added, and the beads were removed using a magnetic particle
collector (Dynal). The supernatant, containing enriched SE
cells was removed. The beads were washed twice with culture
medium and all supernatants were pooled. Removal of the
lymphocytes was verified by microscopic examination of a
cytospin preparation with haematoxylin and eosin staining.
After treatment with magnetic beads, all suspensions
contained less than 15% of lymphocytes.
Lyophilisation and glycolipid extraction
Similar packed cell volumes from untreated or bead-treated
samples, as well as frozen tumour blocks of similar size were
lyophilised overnight in a Freeze Mobile 12SL (Virtis Sentry,
Gardiner, USA). Upon lyophilisation, samples were sent to
Philadelphia in numbered tubes, without any information on
tumour histology to assure an objective assay. Glycolipids
were extracted from an approximately equal packed volume
of tumour cells using isopropyl alcohol-hexane-water
(55:25:20,v/v/v), as described previously (Kannagi et al.,
1982). Total lipid extracts were partitioned into an upper and
lower phase according to the method of Folch-Pi et al.
(1951). The upper phase was desalted using C18 reverse-
phase columns (Analytichem, Harbor City, USA).
Glycolipid analysis
Major glycolipids (CMH, CDH, CTH) were detected using
orcinol staining. Specific glycolipids were identified by co-
Table I Glycolipid specificity of monoclonal antibodies used
Antibody Glycolipid structurea Glycolipid name
Globo-series
b Glcfll-,Cer CMH
b Galfll-+4Glcfl-4Cer CDH
IA4-EIO GalaI-4GalflI-4Glcfll-*Cer Gb3 (CTH)
MC630 GalNAcfl1-3Galal-4Galll-*4Glcll->Cer Gb4 (globoside)
MC630 Gal,Bi1--3GalNAcfl--- 3Gala1l-A4Galfil-4Glcll---1Cer Gb5 (SSEA-3)
MC813 NeuAca2--3Galfll-3GalNAcfl-+3Galal--14Galll--*4Glcfll--.Cer GL7(SSEA-3/4)
MC813 GalNAc,Bl--3Galfll-*3GalNAcfll--3Gala1l-4Galpl-4Glc,B1-Cer GL9 (SSEA-3/4)
3
NeuAa2-3Galfll
Lacto-series Galfl-+4GlcNAcfll-3Galfll---4Glcfl->Cer Lex (SSEA-1)
MC480 3
Fucal
Gal,Bl- 14GlcNAcfll---3Galfll--14GlcNAcfl--*3Galfl---*4Glcfll Cer extLex (SSEA-1) MC480 3 3
Fucal [Fucal],
Ganglio-series NeuAca2-*8NeuAcoc2-3Gafll-*4GlcflI-*Cer GD3
R24 NeuAca2-*8NeuAcac2--8NeuAcac2--3Galll-->4Glcll-*Cer GT3
A2B5
aGlobo-series glycolipids contain Galal--4Gal; lacto-series glycolipids containGlcNAcil->3Gal;ganglio-series containNeuAca2--3Gal.bNo
antibodies to detect CMH and CDH are available; these molecules are detected using orcinol staining.Glycolipids of germ cell tumours
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migration with pure glycolipid standards and by immuno
staining with specific monoclonal anti-carbohydrate anti-
bodies (Fenderson et al., 1987; Andrews et al., 1990). In brief,
5 il of each glycolipid sample was streaked onto Whatman
HP-FK silica gel plates and subjected to ascending
chromatography using a solvent system of chloroform-
methanol-water (50:40:10v/v/v) containing 0.05% (w/v)
calcium chloride. After drying, the chromatography plates
were coated with 0.5% (w/v) polyisobutylmethacrylate
(Aldrich, Milwaukee, MI, USA) in diethyl ether for 1 min,
blocked for 2 h with 5% bovine serum albumin (BSA)
(Sigma, St Louis, MO, USA) in phosphate-buffered saline
(PBS), and then reacted with primary antibody overnight at
4°C. Bound antibody was detected using a 2 h incubation at
4°C with alkaline phosphatase-conjugated goat anti-mouse
antibody (HyClone, Logan, USA) diluted 1:1000. Colour
reaction was obtained through incubation with bromochlor-
oindolyl phosphate (Fisher Biotech, NJ, USA) and nitroblue
tetrazolium (Sigma) for 1 h at room temperature (Harlow
and Lane, 1988).
Monoclonal antibodies
Anti-carbohydrate monoclonal antibodies (MAbs) were
obtained and used as described previously (Fenderson et
al., 1987). Gb3 was detected using MAb IA4-E1O (Fenderson
et al., 1987); Gb4 and Gb5 were detected using MAb MC630
to SSEA-3 (Kannagi et al., 1983a); GL7 was detected using
MAb MC813 to SSEA-4 (Kannagi et al., 1983b); Lex was
detected using MAb MC480 to SSEA-1 (Solter and Knowles,
1978; Gooi et al., 1981); GD3 was detected using MAb R-24
(Dippold et al., 1984); GT3 was detected using MAb A2B5
(Eisenbarth et al., 1979). The glycolipid carbohydrate
structures recognised by these reagents are listed in Table I.
Orcinol
Gangliosides are designated according to the nomenclature of
Svennerholm (1964). Glycolipids are designated according to
the recommendations of the IUPAC Nomenclature Commit-
tee (IUPAC-IUB, 1978).
Results
Glycolipid profiles of tymphocyte-depleted seminoma cell
suspensions
SEs are known to contain infiltrating lymphocytes (Mostofi,
1980, 1984), which could influence our tumour glycolipid
analysis. Therefore, magnetic anti-CD2 coated beads were
used to remove these inflammatory cells from SE cell
suspensions. Thin-layer chromatography and subsequent
orcinol or immunostaining for SSEA-1, SSEA-3 and SSEA-
4, using pellets of either untreated or lymphocyte-depleted
cells, revealed that lymphocyte depletion did not result in a
marked change in glycolipid profile (Figure 1). Orcinol
staining revealed an additional band of unknown origin in
the bead-treated samples that did not react with any of the
MAbs included in this study. Whether this band is specific for
SEs needs further investigation. Gb3 and Gb4 were the major
glycolipids in all five SE samples. Two tumours, TL1049 and
TL3544, were found to have high levels of glycolipid
expression. These tumours contained an extended GL7
glycolipid, referred to as GL9, previously shown to be
present in NT2 cells (Andrews et al., 1990).
Glycolipid profiles of intact tumour tissues
Lymphocytes in SEs did not interfere with our glycolipid
analysis. Because of this finding and as expression of certain
glycolipids has been found immunohistochemically to occur
SSEA-1
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Figure 1 Effect of lymphocyte depletion on glycolipid content of human seminomas. Upper and lower phase glycolipids were
obtained from cell suspensions that were either untreated (-) or treated (+) with magnetic immunobeads to remove lymphocytes.
Glycolipid standards are included on the right side of each plate (S). Plates were developed with chloroform-methanol-water
(50:40:10) containing 0.05% calcium chloride and either stained for carbohydrate using orcinol-sulphuric acid spray (Orcinol) or
labelled with monoclonal antibody directed to either SSEA-1, SSEA-3 or SSEA4. Lower phase glycolipids were included on
Orcinol and SSEA-3 plates; upper phase glycolipids were included on SSEA-1 and SSEA-4 plates. Results represent bound antibody
detected using alkaline phosphatase-conjugated second antibody. Asterisks (*) note a contaminant in lymphocyte depleted samples
(Orcinol), and non-specific binding of second antibody to lipids present in lower phase extracts (SSEA-3). Samples are identified by
number in Table II.
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specifically in CIS and TGCT cells (Kang et al., 1995), we
assumed that non-malignant cells in NSs would not interfere
with the glycolipid analysis either. Therefore, we proceeded to
use lyophilised tissue samples from snap frozen tumours for
subsequent analyses. The results of our orcinol and
immunostaining analyses are shown in Figure 2. All data
concerning the glycolipid profiles of the 50 analysed samples
are listed in Table II and summarised in Table III.
Compared with normal testicular parenchyma, CIS-
containing parenchyma was characterised by the abundant
presence of Gb3 and Gb5, and an increase in the expression
of Gb4 and GL7.
Of 21 SEs analysed, all tumours expressed the globo-senes
glycolipid GL7, whereas CDH was found in nine, Gb3 and
Gb4 in 19 and Gb5 in ten SEs. The ganglio-series glycolipids
GD3 and GT3 were present in 14 and ten SEs respectively.
The expression level of the distinct glycolipids varied among
the SEs. With regard to GL7 in particular, two groups of SEs
could be distinguished: one with a low and one with a high
level of expression. Since tumour cell enrichment by
lymphocyte depletion did not result in a marked change in
detection levels of the glycolipids and similar-size tumour
blocks were used for glycolipid extraction, the high and low
glycolipid levels found in the tumour blocks apparently
reflect differences in expression level and not a variation in
the amount of tumour cells present in each sample.
In contrast to the SEs, only one ofwhich expressed Lex, all
ECs contained this marker. CDH and Gb5 were also present
in all ECs. These tumours further expressed Gb3, Gb4 and
GL7 in all samples, as did the majority of the SEs. Two ECs
were found to weakly express GD3, whereas only one tumour
contained GT3.
The YSs did not display a clearly defined glycolipid
profile. One tumour expressed Gb3, Gb4, GbM, GL7 and Lex.
Two tumours expressed Gb3, Gb4 and GD3, either in
combination with Lex or GT3. One tumour expressed Gb5,
GL7, Lex and GD3. Two YSs completely lacked all four
globo-series glycolipids: one contained Lex only, while the
other, derived from a xenografted mixed tumour, had GD3
and GT3.
Compared with SEs and ECs, the nine (mixed) NSs had
reduced levels of globo-series glycolipids, especially Gb3 and
Gb5, whereas CDH and Lex were found in the majority of
the samples. Eight NSs contained GD3 and GT3. The highest
ganglioside levels were found in tumours with at least an MT
component. The pure MT had trace amounts of Gb3, Gb4
and GL7, besides high levels of GD3 and GT3.
The SS did not express GL7 and Lex. The dermoid cyst
contained Gb3, Gb4, GL7, GD3 and GT3. One B-cell
lymphoma contained some CDH, whereas the other had low
levels of CDH, Gb4, GL7 and Lex.
Discussion
We analysed whether the glycolipid content of human NS cell
lines reflects the situation in primary tumours, using thin-
layer chromatography and carbohydrate immunostaining. We
DCDH
Gb3
Gb4
5 10 15 20 25 30 35 40 45 S
-Gb4
- Gb5
D IU 13 LU 25 30 35 4U 45 5
- GL7
5 10 15 20 25 30 35 40 45 S
Figure 2 Thin-layer chromatography immunostaining analysis of globo-series glycolipid expression in lower phase and upper phase
extracts of human testicular germ cell tumours. Glycolipid standards are included on the right side of each plate (S). Plates were
developed with chloroform-methanol-water (50:40:10) containing 0.05% calcium chloride and either stained for carbohydrate
using Orcinol (upper phase) or labelled with monoclonal antibody directed to SSEA-3 (middle phase) or SSEA4 (lower phase).
Results represent bound antibody detected using alkaline phosphatase-conjugated second antibody. Samples are identified by
number in Table II.
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also analysed the glycolipid content of CIS and SEs,
particularly to reveal the relationship of the latter with ECs.
SEs and testicular parenchyma containing CIS were
characterised by similar glycolipid patterns. This result
attests to the phenotypic similarity of CIS and SE cells.
As expression of gangliosides is regarded as a marker of
differentiation (Fenderson et al., 1987), the finding of GD3
and GT3 in many SEs confirms the thought that SEs form a
heterogeneous population. It can be speculated that the
ganglioside-containing SE cells are derived from precursor
Table II Glycolipids of human germ cell tumours
No. Tumour CDH Gb3 Gb4 Gb5 GL7 Lex GD3 GT3
CIS and seminomas
13. TL1804 (CIS/SE)
35. TL3724 (CIS/NS)
1. TL7573
2. TL614
14. TL3174
15. TL287
16. TL8225
19. TL2207T3
26. TL1487
27. TL229
29. TL2207T1
37. TL8837
38. TL9089
39. TL212
41. TL8763
42. TL74
45. TL8888
47. TL539
48. TL1049
49. TL3544
50. TL8285
51. TL9244
52. TL4873
+ ++ ++
+ + ++
++ ++
++ ++
++ ++ ++
+ +++ +++
+ + +
++ ++
+ +
+ +
+
+
++ ~++
+++
++
++ +++ +++ +++
++ ++
+ ++
+ ++
+ +++ ++ ++
+ +++ +++
++ ++
++ ++
+ +++ +++
+ +
+ +
+ ++
+ ++
++ ++
+ +++ +++ ++ ++
+ ++ +
+ ++ +
+ ++ +
+
+
+
++
++ ++
+ +
++ +
++ +
+
+ + +
++ ++
+ +++ ++
+
+
Embyronal carcinomas
5. TL5207
7. TL2207T2
17. TL3635
28. TL524
43. TL269
46. TL87
++ +++ +++ +++ +++ ++
+++ +++
+ +
+ ++ ++
+ ++ ++
++ ++ + ++
++ ++ +++ +++
+ ++ + +
+ ++ ++ +
+ + + ++ +++ +++ +++
Yolk sac tumours
30. TL37R21
40. TLI013
4. TL7873 (MT)a
9. TL6322 (EC)a
25. TL1973 (EC,IT)a
36. TL7162 (EC)a
+ +
+ ++
+ ++ ++
~~~~
+ ++ ++ ++ +
Non-seminomas
8. TL6745 (MT)
10. TL3819 (IT,MT,YS,CC)
11. TL3035 (MT,YS)
22. TL37T1 (EC,IT,MT,YS)
23. TL6936 (MT,IT,YS)
31. TL189 (WT)
32. TL1348 (EC,IT,MT,YS)
33. TL37T2 (MT,EC)
34. TL8007 (EC,IT,MT,YS)
Spermatocytic seminoma
44. TL8743
+
+
+ +
+
+ +
++ + +
++ + ++
+
~~~~~+ + ++
+ ++ ++
+ ++ ++
++
++ +
+
++ ++
+++
+ ++
+
Non-germ cell tumours
3. TL8558 (DC)
18. TL4224 (L)
20. TL6661 (L)
Testicular parenchyma
12. TL1540
24. TL1541
+
++ ++
+ +
+ + +
+ +
+
+
++ +
+ + +
+ +
+++
+ +
+ +
+ +
+ +
+++
+
+
+
+
+
+
+ +
+
Results represent a synthesis ofthin-layerchromatography orcinol and immunostaining data. The scale is negative (no symbol) to strongpositive
(+ + +). Lex antigen was carried on multiple glycolipid species. CC, choriocarcinoma; CIS/SE, CIS/NS, carcinoma in situ-containing testicular
parenchyma adjacent to a seminoma and non-seminoma respectively; DC, dermoid cyst; EC, embryonal carcinoma; IT, immature teratoma; L,
lymphoma of the testis; MT, mature teratoma; YS, yolk sac tumour. a Four YSs contained minor amounts ofnon-YS cells, as indicated; WT,
testicular Wilms' tumour ofgerm cell origin.
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Table m Glycolipid expression in human germ cell tumours
Cell type
Glycolipid N (2) CIS/SE (23) EC (6) YS (6a) NS (8)
Globo-series
CDH 1, + I1, + 6, + + 3, + 6, + +
Gb3 21, + + 6, + + 3, + 6, +
Gb4 2, + + 22, + + 6, + + + 3, + + 7, + +
Gb5 12, + + 6, + + 2, + + 5, +
GL7 2, + 23, + + + 6, + + 2, + + 7, + +
Lacto-series
Lex 1, + 6, + + 4, + + 6, + +
Ganglio-series
GD3 1, + 15, + + 2, + 4, + + 7, ++
GT3 1, + 1, + 2, + 7, +
The number ofsamples (ofthe total number analysed, indicated in brackets) expressing the indicated marker and the average immunostaining
intensityare shown. Glycolipid structures wereidentifiedin thisreportby: (i)co-migration onthin-layerchromatographyplateswithpureglycolipid
standards and (ii) by immunostaining using specific anti-glycolipid monoclonal antibodies. CIS, carcinoma in situ-containing testicular
parenchyma; EC, embryonal carcinoma; N, normal testicularparenchyma; NS, non-seminomatoustesticulargermcell tumour; SE, seminoma;YS,
yolk sac tumour. aFour YSs contained minor amounts ofother non-seminomatous cell types, as indicated in Table II. The results ofa testicular
Wilms' tumour were not included in the average staining intensity ofnon-seminomas. Expression is from absent (no symbol) to strong (+ + +).
cells that express globo-series glycolipids only. Whether
primordial germ cells, the benign counterparts of SE cells,
also show heterogeneity concerning glycolipid expression
could be analysed in future studies, using immunohistochem-
istry.
Two tumours, TL1049 and TL3544, were found to have
high levels of glycolipid expression and contained an
extended GL7 glycolipid, referred to as GL9, previously
shown to be present in NT2/D1 cells (Andrews et al., 1990).
Interestingly, these tumours have previously been shown to
contain a mutant ras gene (Olie et al., 1995a) and exhibit an
aberrant in vitro behaviour (Olie et al., 1995b). Sixteen other
SEs, comprising three ras mutant and 13 wild-type tumours,
showed no correlation between the presence of a ras mutation
and high glycolipid expression, while none of these ras
mutant SEs expressed GL9.
No SE cell lines are available at present, although one cell
line, designated S2, has been described to have some
seminomatous characteristics (von Keitz et al., 1995).
Analysis of the glycolipid profile revealed that S2 cells
contain some Gb3, but mainly express CDH, Gb4, GL7 and
Le', while Gb5 is not present (Wenk et al., 1994). We
confirmed the reported data on S2 in a blind test during this
study, which allowed identification of the S2 origin of the
sample (not shown). In combination with our findings of
CDH and Lex mainly in primary ECs (see below), and the
absence of Gb5 in half of the SEs, the suggestion that S2
represents a tumour cell with an intermediate phenotype
between SE and EC, but not a pure SE (Wenk et al., 1994;
von Keitz et al., 1995), is supported.
All SEs (except one) lacked Lex, while this glycolipid was
present in all ECs. This marker can thus be used for the
differential diagnosis between SE and EC. In primary ECs,
the expression of CDH is markedly enhanced, as compared
with cell lines. This could mean that CDH is more rapidly
converted into the derived globo-series glycolipids in cell lines
cultured in vitro, especially as the expression of globo-series
glycolipids is similar in primary tumours and cell lines.
Results obtained in a NATO advanced study workshop
(Andrews et al., 1996) on the expression of cell-surface
antigens by TGCT cell lines, applying immunohistochemistry
and immunoflow cytometry, largely confirm our data on Lex,
detected with antibodies to SSEA-1 (as well as those on
SSEA-3 and SSEA-4 expression). However, our data and
those presented by Wenk et al. (1994) show some differences
with those obtained by Andrews et al., (1996). The latter
detected SSEA-1 antigen on all cells from the EC cell lines
H12.1 and H12.2, whereas Wenk et al., 1994 could not detect
this marker on these cell lines, using glycolipid analysis. Most
likely, this is due to the fact that although SSEA-1 antigen
can be carried on glycolipids, it is mainly presented at the cell
surface as glycoprotein (Fenderson et al., 1993). The
presented data suggest that this is true for the H12.1 and
H12.2 cell lines. However, our results imply that EC cells in
primary tumours express the SSEA-1 antigen on the Lex
glycolipid, alone or in addition to expression on glycopro-
teins (which was not investigated in our study), whereas in
vitro, this antigen is mainly carried on glycoproteins. Taken
together, the studies on cell lines indicate that EC cell lines
heterogeneously express SSEA-1 and reduced expression of
this marker in cell lines could indicate its loss upon prolonged
in vitro culture. Our data, those from the NATO workshop
and those presented by Wenk et al. (1994) implicate the
presence in ECs of a large, globo-series glycolipid-expressing
stem cell population, which (heterogeneously) expresses
SSEA-1, in vitro mainly carried on glycoproteins and in vivo
(also) on glycolipids.
Our data on ECs are not in keeping with those obtained
by Motzer et al. (1988) and Damjanov et al. (1982), who
could not immunohistochemically detect SSEA-1 expression
in ECs. The use of MAb P12 by Motzer et al., 1988 whereas
we used MAb MC480 might account for this difference. The
use of MC480 in combination with a two-step detection
method by Damjanov et al. (1982) might account for their
findings, as they also failed to detect SSEA-3 expression in
SEs (using the two-step approach), which was detected by us
in the present study and in an immunohistochemical analysis
using the avidin-biotin method (not shown).
The glycolipid patterns of the two pure YSs, TL1013 and
TL37R21, the latter derived from a xenografted NS with a
YS component, are similar to those described for YS cell
lines. The four primary YSs with minor populations of other
non-seminomatous cell types (as indicated in Table IL), did
not display a clearly defined glycolipid profile. These
heterogeneous glycolipid profiles could not be related to the
types of tumour morphology distinguished by Pera et al.
(1987), i.e. solid and reticulated YS resembling rodent visceral
and parietal endoderm respectively. In contrast to four
previously described YS cell lines (one lacking all detectable
glycolipids) (Wenk et al., 1994), these four primary YSs
contain Lex. Presence of this glycolipid could probably be
attributed to EC or teratoma cells, that were immunohisto-
chemically detected in these YSs as minor cell populations.
Damjanov et al. (1982) detected Lex immunohistochemically
in the YS cells of tumours containing at least EC and YS
components, whereas pure YSs were not analysed. We
conclude that pure YSs are characterised by at least lacking
Gb5, GL7 and Lex.
Our data on pure ECs and NSs with differentiated
components, are in agreement with those reported for theGlycIpids of germ cel bwnors
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Maturation!
differentiation
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ganglio: GD3, GT3
Figure 3 Speculative model of the development of testicular
germ cell tumours from carcinoma in situ. taking into
consideration the glycolipid expression patterns of the various
tumour types.
cell line NT2 (Wenk et al.. 1994). EC cells express almost
exclusively large amounts of globo-series glycolipids (apart
from Lex). The NSs with differentiated components are
characterised by a lower expression of the globo-series
glycolipids, especially Gb3 and Gb5. expression of the
lacto-series glycolipid Lex in the majority of the tumours
and presence of the gangliosides GD3 and GT3. at the
highest levels in tumours with at least an MT component.
These data confirm the morphological observations of the
presence of a minor stem cell population in differentiated
NSs. Although our semi-quantitative analysis of the
glycolipid expression in pure tumours indicates which
glycolipids are expressed by the various cell types, an
immunohistochemical approach could be used to study the
distribution of glycolipids. especially concerning the non-
seminomatous cell types in mixed tumours.
Our data on the spermatocytic seminoma support the
contention that this tumour type is a separate GCT entity.
not derived from CIS cells (Burke and Mostofi. 1993;
Cummings et al., 1994). Based on their glycolipid content.
the spermatocytic seminoma, non-GCTs and the normal
parenchyma of the testis could readily be discriminated from
TGCTs and parenchyma containing CIS.
In conclusion, our analysis of the glycolipid content of
human primary TGCTs confirms the data obtained on non-
seminomatous cell lines (Wenk et al., 1994). Globo-series
glycolipids are highly expressed in ECs, whereas the
expression of especially Gb3 and Gb5 is reduced in
differentiated non-seminomatous elements. In addition. we
show that the globo-series glycolipids are expressed at similar
levels in CIS. SEs and ECs. The expression of LeX by ECs
allows discrimination between this tumour type and SEs.
which do not express this marker. Gangliosides are found in
many SEs and almost all differentiated NSs. but are rare in
ECs. These results could be integrated in the speculative
model shown in Figure 3. Primitive cells, i.e. CIS and SE
cells, are characterised by globo-series glycolipids. These
tumour cells could develop along two pathways. Either they
mature (differentiate) in the germ cell lineage and start
expressing gangliosides. or they are reprogrammed to become
pluripotent EC cells and start expressing lacto-series Lex.
When these reprogrammed cells mature (differentiate) into
various lineages they start expressing gangliosides as well.
The present data fit into the linear progression model, but do
not prove it. Studies comparing the glycolipid proffle of CIS
and adjacent tumour. either SE or NS, should be performed
to further investigate this model. In addition, it would be
interesting to see if modulation of the glycolipids can change
the phenotype of the tumour cells. Preliminary studies with
NT2 (EC) cells using the glycosylceramide synthase inhibitor
PDMP indicate that glycolipid depletion results in changed
growth and shape of the cells (unpublished observations).
This issue might also be addressed using transfection with
glycosyltransferase genes to change glycolipid patterns. At
present, these studies have to be limited to non-seminoma-
tous cell types. as SE cell lines are not available.
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